NCT01227720 - Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products. | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions

Tobacco Dependence

Interventions

DRUG

Experimental Nicotine Replacement Therapy (NRT) 2 mg

2 mg Single-dose of new NRT product (NSL2L)

DRUG

Experimental Nicotine Replacement Therapy (NRT)

4 mg Single-dose of new NRT product

DRUG

Marketed Nicotine Lozenge

2 mg Single-dose of marketed lozenge

DRUG

Marketed Nicotine Lozenge

4 mg Single-dose of marketed lozenge

Trial Locations (2)

Lund University Hospital Clinical Trial Unit, Lund

McNeil AB Clinical Pharmacology R&D, Lund